We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
FDA reviewers are recommending approval of Vanda’s sleep drug tasimelteon for the visually impaired, overcoming initial disagreements with the company over acceptable primary endpoints. Read More
Drugmakers should establish a company task force of upper management and quality personnel to prevent drug shortages, according to new good practice guidelines developed by the European Federation of Pharmaceutical Industries and Associations (EFPIA). Read More